Aims To assess the prevalence and clinical impact of reductions in the skeletal muscle mass
of patients with chronic heart failure (HF). Chronic HF is accompanied by co-morbidities that …

Background Skeletal muscle wasting is an extremely common feature in patients with heart
failure, affecting approximately 20% of ambulatory patients with even higher values during …

Background Muscle wasting can be accelerated by chronic diseases such as heart failure
and is one of the major causes of disability, morbidity, and mortality in this population. We …

Patients suffering from chronic heart failure (CHF) show an increased prevalence (~ 20% in
elderly CHF patients) of loss of muscle mass and muscle function (ie sarcopenia) compared …

Body wasting is a serious complication that affects a large proportion of patients with heart
failure. Muscle wasting, also known as sarcopenia, is the loss of muscle mass and strength …

Objectives Skeletal muscle wasting, also known as sarcopenia, has recently been identified
as a serious comorbidity in patients with heart failure (HF). We aimed to assess the impact of …

Background Cachexia, characterized by loss of muscle with or without loss of fat mass, is a
poor prognostic factor in patients with heart failure (HF). However, there is limited …

Patients with heart failure are frequently limited in their exercise capacity. Although this
clinical phenomenon is mostly attributed to the failing myocardium, the effects of skeletal …

Background To describe the prevalence of sarcopenia in ambulatory patients with heart
failure with preserved ejection fraction (HFpEF) and its relation to reduced exercise capacity …

Aims Changes in heart failure (HF) patients' body composition may be associated with
reduced exercise capacity. The aim of the present study was to determine the overlap in …